Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.  

Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.   

Biotechnology

Therapeutics

Metaphore Biotechnologies

Lovisa Afzelius

Chaz Hinzman

Marcin Paduch

The Research and Discovery team at Metaphore Biotechnologies focuses on leveraging the company's MIMiC™ platform to identify and develop novel therapeutics. This multidisc

About

People

Abdul Bais Kadli

Alexandre Fassio

Ben Goldberg

Evan Latowsky

Jenny Cheng

Katherine Norwood

Magdalene Namwira

Prakrith Vijey

Robert W. Link

Tatiana Athanasopoulos